NEW YORK, Jan. 7, 2022 /PRNewswire/ -- Hematopoietic Stem Cells Transplantation Market Facts at a Glance-
NEW YORK, Jan. 7, 2022 /PRNewswire/ -- Hematopoietic Stem Cells Transplantation Market Facts at a Glance-
Didn't Find What You Were Looking For? Customize Report-
Don't miss out on the opportunity to speak to our analyst and know more insights about this market report. Our analysts can help you customize this report according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short time.
We offer USD 1,000 worth of FREE customization at the time of purchase. Speak to our Analyst now!
According to the recent market study by Technavio, the Hematopoietic Stem Cells Transplantation Market Size is expected to increase by USD 1.99 billion from 2020 to 2025, progressing at a CAGR of 6% during the forecast period. The report provides a detailed analysis of drivers & opportunities, top winning strategies, competitive scenario, future market trends, market size & estimations, and major investment pockets.
North America will register the highest growth rate, occupying 40% of the global market share. The US and Canada are the key markets for hematopoietic stem cells transplantation in North America. The market growth in this region will be slower than the growth of the market in Asia.
Download FREE Sample: for more additional information about the key countries in North America
Vendor Insights-
The hematopoietic stem cells transplantation market is fragmented due to the presence of several regional and global players. Vendors are adopting various organic and inorganic growth strategies to stay ahead of the competition.
AllCells Corp.: The company offers bone marrow products that are collected by qualified clinicians from the posterior iliac crest of a healthy donor.
bluebird bio Inc.: The company offers stem cells products under the brand name Zynteglo.
FUJIFILM Holdings Corp.: The company offers stem cells under the brand name iCell.
Lineage Cell Therapeutics Inc.: The company offers stem cells therapies under the brand names OpRegen, OPC1, and VAC2.
Lonza Group Ltd.: The company offers a variety of hematopoietic cell types from different tissue sources such as bone marrow, cord blood, and peripheral blood.
Find additional highlights on the vendors and their product offerings. Download Free Sample Report
Regional Market Outlook
The hematopoietic stem cells transplantation market growth in North America will be significant during the forecast period. The increasing prevalence of various types of cancer is the key factor driving the growth of the hematopoietic stem cells transplantation market in North America. The report also offers detailed insights into the growth of the market across Asia, Europe, and ROW. The UK, Germany, and China are identified as the prominent markets for hematopoietic stem cells transplantation.
Download our FREE sample report for more key highlights on the regional market share of most of the above-mentioned countries.
Latest Drivers & Trends Driving the Market-
HSCT is increasingly gaining prominence in the treatment of leukemia, lymphoma, immune-deficiency illnesses, hemoglobinopathies, congenital metabolic defects, and myelodysplastic and myeloproliferative syndromes. This can be attributed to the high efficacy of HSCT. With improvements in conditioning techniques, donor selection, and post-transplant care, the demand for HSCT is increasing significantly in both developed and developing countries globally. Moreover, the increase in funding and research grants for the development of regenerative therapies such as allogeneic stem cell therapies are resulting in the development of novel therapies. All these factors are expected to fuel the market growth during the forecast period.
Many vendors and research organizations are focusing on the development of personalized medicines that can offer treatment based on patients' needs and preferences. Some of the benefits of personalized medicine include low risk of immune rejection, no need for embryonic stem cells, reduced need for anti-rejection drugs, and less chance of developing GvHD. Such benefits are increasing the development of personalized medicines using mesenchymal stem cells. This trend is will have a positive impact on the growth of the market during the forecast period.
Find additional information about various other market Drivers & Trends mentioned in our FREE sample report.
Related Reports:
Autologous Cell Therapy Market by Product and Geography - Forecast and Analysis 2021-2025
Biotechnology Reagents Market by Technology and Geography - Forecast and Analysis 2021-2025
Hematopoietic Stem Cells Transplantation (HSCT) Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2020 |
Forecast period |
2021-2025 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6% |
Market growth 2021-2025 |
USD 1.99 billion |
Market structure |
Fragmented |
YoY growth (%) |
5.85 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 40% |
Key consumer countries |
US, UK, Germany, Canada, and China |
Competitive landscape |
Leading companies, competitive strategies, consumer engagement scope |
Companies profiled |
AllCells Corp., bluebird bio Inc., FUJIFILM Holdings Corp., Lineage Cell Therapeutics Inc., Lonza Group Ltd., MEDIPOST Co. Ltd., Merck and Co. Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and ThermoGenesis Holdings Inc. |
Market Dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for the forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
Share this article